Cafepharma Today

June 5 2025 - GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
Bispecific cancer drugs, data caveats and funding alarms: 3 takeaways from ASCO
FDA’s Elsa AI is here, and the industry has questions
Merck gains U.S. patent office support in Keytruda dispute
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Can Merck Finally Get Past the Vioxx Scandal?
Wall Street Cheat Street
Saturday, July 20, 2013 - 11:27am
tags:
Merck, Vioxx, lawsuits
Three Future Winners and One Major Loser in the HCV Wars
Motley Fool
Saturday, July 20, 2013 - 11:26am
tags:
Gilead Sciences, AbbVie, hepatitis, hepatitis C, Bristol-Myers Squibb, Idenix
Alnylam Targets New Highs On Data Supporting RNAi
Seeking Alpha
Saturday, July 20, 2013 - 11:18am
tags:
RNA interference, Alnylam
Pacira Reports New Data
Yahoo/Zacks
Saturday, July 20, 2013 - 11:12am
tags:
Pacira, EXPAREL, pain management
Cytori Surges on Medistem Agreement
Yahoo/Zacks
Saturday, July 20, 2013 - 11:10am
tags:
Cytori, MediStem, stem cells
Chelsea's NDA for Northera Accepted
Yahoo/Zacks
Saturday, July 20, 2013 - 11:09am
tags:
Chelsea Therapeutics, Northera, neurogenic orthostatic hypotension
CEL-SCI Reports on NYSE MKT Noncompliance Notice and Compliance Plan
Yahoo/BusinessWire
Saturday, July 20, 2013 - 11:08am
tags:
Cel-Sci
BioCryst Pharmaceuticals: A Winning Investment For The Long Term
Seeking Alpha
Saturday, July 20, 2013 - 11:07am
tags:
Biocryst
Is This Biopharmaceutical Company Ahead Of Its Time?
Motley Fool
Saturday, July 20, 2013 - 11:05am
tags:
Regeneron
Vivus Said to Be Close to Settlement With First Manhattan
Bloomberg
Saturday, July 20, 2013 - 11:04am
tags:
Vivus
Pipeline Progress at Synergy Pharma
Yahoo/Zacks
Saturday, July 20, 2013 - 11:03am
tags:
Synergy Pharmaceuticals, irritable bowel syndrome, plecanatide
Don't Be Fooled By Celsion's Latest Rally
Seeking Alpha
Saturday, July 20, 2013 - 11:02am
tags:
Celsion
Hisun Pharmaceutical Doubles Down On Celsion
Seeking Alpha
Saturday, July 20, 2013 - 11:01am
tags:
Hisun, Celsion
DEALTALK-Biotech takeover interest more fad than fashion
Reuters
Saturday, July 20, 2013 - 10:54am
tags:
M&A
Iroko Pharmaceuticals Unveils Estimated Terms of IPO
Wall Street Journal
Saturday, July 20, 2013 - 10:50am
tags:
Iroko Pharmaceuticals
Actelion Beats on Earnings and Revs
Yahoo/Zacks
Friday, July 19, 2013 - 12:12pm
tags:
earnings, Actelion
DNA Giant Illumina's Newest Partnership
Seeking Alpha
Friday, July 19, 2013 - 12:09pm
tags:
Illumina, DNA, OPKO Health, Prolor Biotech, TrovaGene
Intuitive Surgical Declines on Warning Letter From FDA
Bloomberg
Friday, July 19, 2013 - 12:07pm
tags:
devices, warnings, FDA, Intuitive Surgical, robotic surgery
Medical Pot: A Drugmaker Bets on Marijuana to Treat Diabetes, Epilepsy, and More
Bloomberg/Businessweek
Friday, July 19, 2013 - 12:05pm
tags:
marijuana, GW Pharma, diabetes, epilepsy, Sativex, multiple sclerosis
Arena Stock Reacts To Sales Pace
Seeking Alpha
Friday, July 19, 2013 - 11:48am
tags:
Vivus, Arena Pharmaceuticals, Eisai, Belviq, Qsymia

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.